C ontinuous positive airway pressure (CPAP) refers to the application of continuous pressure during both inspiration and expiration in a spontaneously breathing baby. CPAP helps in opening of atelectatic alveoli, splints the airways, reduces work of breathing, and improves the pattern and regularity of respiration. Atelectotrauma, biotrauma, and volutrauma, the key determinants of ventilation-induced lung injury are minimal or absent with this mode of ventilation [1] .
were included in this study. Neonates with GA <28 weeks and ≥37 weeks, neonates with no spontaneous respiration at birth, and neonates with congenital anomalies such as cleft lip, cleft palate, tracheoesophageal fistula, congenital diaphragmatic hernia, and choanal atresia were excluded from the study. The Institutional Ethical Committee approval was taken before starting the study and parental consent was taken before recruiting the cases.
All the eligible preterm neonates were started on bubble CPAP (Fischer and Paykel) with binasal prongs (Hudson prongs). CPAP was started at 5 cm of water and adjusted to minimize the chest retractions. FiO 2 was adjusted to maintain SpO 2 90-94%. Flow of gas was started at 5 L/min and was adjusted until continuous bubbling was noted in the chamber. Surfactant was administered by intubation-surfactant-extubation method for babies with moderate-to-severe RDS on the chest X-ray showing extensive reticulonodular pattern or complete white-out lung fields.
Preterm neonates with minimal or no chest retractions, having a respiratory rate between 40 and 60/min and normal saturation on FiO 2 <30% and positive end-expiratory pressure (PEEP) <5 cm of water, were weaned off from bubble CPAP. Bubble CPAP was considered to be efficacious if the respiratory distress improved and baby could be successfully weaned off from CPAP. (Baby remains off CPAP for the next 72 h). CPAP failure was defined as the need for mechanical ventilation when they remained hypoxic, i.e., SpO 2 <87% despite FiO 2 >60%, PEEP >7 cm of water or had severe retractions on PEEP >7 cm of water or had recurrent apneas.
Maternal, perinatal, and neonatal data were collected in a predesigned pro forma. GA was calculated based on the mother's last menstrual period or expanded new Ballard score. Based on the radiological findings, severity of RDS was graded as mild -mild granulations of lungs, moderate -generalized granularity of lung with air bronchogram with preserved cardiac borders, and severe -whiteout lungs with loss of cardiac borders.
Appropriate statistical tests were applied using software SPSS version 21. Baseline variables were compared between those who could be successfully weaned from CPAP (CPAP-success group) and those who failed (CPAP-failure group). Mean and standard deviation was calculated for continuous variables and percentages were calculated for categorical variables. Univariate analysis was done to study factors responsible for the failure of CPAP using Student's t-test or Chi-square test or Fisher's exact test as appropriate depending on the variable.
RESULTS
A total of 243 preterm neonates were enrolled in the study with a mean GA of 32.4 weeks and mean birth weight of 1831.49 g. Out of these, 151 (62.13%) neonates were male. Among the study population, 25 mothers had preterm premature rupture of membranes. In this study, 167 (68.72%) were cesarean deliveries and 8 (3.29%) neonates received antenatal steroids. The above results are summarized in Table 1 .
Among 243 neonates, 195 (80.2%) were successfully weaned off from CPAP and 48 (19.8%) failed CPAP. The mean birth weight in the CPAP-success group was 2088.71±484.08 g and the CPAP-failure group was 1574.27±596.10 g. The mean GA in CPAP success was significantly higher (33.49±2.24 weeks) than in the CPAP-failure group (31.31±2.78 weeks). The mean age at the beginning of CPAP was lower in success than in the failure group (12.39±11.52 h vs. 14.5±13.38 h). The mean duration of CPAP in the success group was 62.73±30.51 h and in the CPAP failure group was 47.56±53.54 h.
Comparison of maternal and neonatal variables between successful and failure groups is shown in Table 2 . It was found that lower GA (mean <31 weeks) birth weight <1.5 kg, SAS ≥7, severe RDS on chest X-ray, and presence of sepsis were associated with CPAP failure. Table 3 shows the number of cases in CPAP success and failure groups in relation to the time of initiation of CPAP. Out of 243 babies, only 22 babies received surfactant along with CPAP, as shown in Table 3 .
A total of 216 (88.88%) received CPAP alone; out of them, 195 (90.27%) survived and 21 (9.7%) babies expired. Out of 243 babies, 27 (11.11%) babies were kept on ventilation due to CPAP failure. Among 27 ventilated babies, 20 (74.07%) survived and 7 (25.9%) babies died. The most common complication seen in babies put on CPAP was sepsis (66, 27.1%) followed by nasal trauma (45, 18.1%) and shock (3, 1.23%). Periventricular leukomalacia was seen in 2 (0.82%) cases while intraventricular hemorrhage and pneumothorax were seen in 1 (0.41%) neonate each.
DISCUSSION
In our study, 80% of neonates were successfully weaned off from the CPAP and these results were higher than those observed by Koti et al. [1] and Urs et al. [5] . In the present study, 38.3% of the study population were of 32-34 weeks gestation and another 38.3% of population was of 35-37 weeks gestation. About 50.6% of population was of weight ˃2000 g, 19.7% were <1500 g, and 4.1% were <1000 g neonates. Urs et al. included neonates of GA 28 to ˂37 weeks (n=50), and 76% of them were of 32-34 weeks Ajmera et al.
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gestation, 66% had birth weight <1500 g, and 8% <1000 g [5] . In a study by Koti et al., the study population (n=56) consisted of neonates of GA 28-34 weeks, including 55.3% very low birth weight (VLBW) and 17.9% ELBW neonates. More success rate in the present study compared to these studies may be attributed to larger total sample size with a major portion belonging to neonates with later GA and birth weight ˃2000 g. Sandri et al. have shown higher need for respiratory assistance in male neonates with RDS. Similar to the study by Urs et al., outcome of bubble CPAP did not vary between genders in this study [6] . Statistically significant CPAP success was seen in neonates born to mothers who had received antenatal steroids in a study by Urs et al. (p˂0.001) and Koti et al. (p<0.02) . Success was higher in neonates who were given antenatal steroids; however, no such significance was found in studies by Sethi et al. and Shamil et al. [7, 8] . In our study, the percentage of neonates who received antenatal steroids (3.2%) was lower in comparison to other similar studies.
In this study, the mean age at initiation of CPAP was 13.44 h of life, which was higher than that observed in a study by Urs et al. (5.5 h) . This could be due to delayed presentation of the neonates to this hospital thus delaying the treatment. Cochrane systematic review concluded that the application of CPAP early in the course of the disease as compared to late CPAP was associated with a significant reduction in subsequent use of invasive ventilation [9] . In the present study, CPAP-success rate was more in neonates in whom CPAP was started early (˂24 h, p=0.04) similar to the study by Shamil et al. (p=0.024).
Verder et al. published the first randomized controlled trial of surfactant instillation during CPAP showing that in infants with moderate-to-severe RDS, the need for subsequent mechanical ventilation could be reduced by half after a single dose of surfactant [10] . The effect was more pronounced if the surfactant treatment was given early in the course of the disease [10] . In our study, surfactant was given to 22 babies (9.05%), which was lower in comparison to the results observed by Koti [7] .
In the present study, 48 (19.8%) out of 243 neonates were considered as CPAP failure, of which 20 neonates were ventilated and 28 neonates (11.5%) died. Mortality rate was more in preterm neonates with GA 28-31 weeks (8.64%, n=21) and neonates with birth weight ˂1500 g (8.23%, n=20). The high mortality rate in this study compared to the study by Koti et al. (10. 7%) may be explained by inadequate usage of antenatal steroids, delay in initiation of CPAP, and lesser use of surfactant. Indian studies on CPAP have shown a failure rate of 25-50%. There were few limitations of this study. There was no monitoring protocol for the patients on CPAP.
CONCLUSION
The efficacy of CPAP in neonates with mild-to-moderate RDS in moderate preterm neonates is very well demonstrated despite the low usage of antenatal steroids, surfactant, and delayed initiation of CPAP. Extreme preterm neonates, VLBW neonates with severe RDS on chest X-ray are at risk of failure of CPAP. 
